| Over a week ago |
|
Initiation
|
Truist analyst Scot… Truist analyst Scot Ciccarelli initiated coverage of Dollar Tree with a Buy rating and $162 price target. The analyst said that, despite several years of disappointing performance and concerns over rising inflationary pressures on low-to-middle income consumers, he believes that Dollar Tree's recent price increase will result in a "sizable" acceleration in sales and profits. ShowHide Related Items >><< - $136.89 /
-0.225 (-0.16%) - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- $136.89 /
-0.225 (-0.16%) - 01/12/22 Truist
- Dollar Tree initiated with a Buy at Truist
- 12/14/21 Piper Sandler
- Dollar Tree response to Mantle Ridge 'fell flat,' says Piper Sandler
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- $136.89 /
-0.225 (-0.16%) - 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- $136.89 /
-0.225 (-0.16%) - 11/12/21
- Mantle Ridge builds $1.8B interest in Dollar Tree, WSJ reports
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- $136.89 /
-0.225 (-0.16%) - 01/10/22
- Fly Insider: Orbsat, Airbnb among week's notable insider trades
- 12/13/21
- Wall Street in Fives - Must Read Lists for Monday
- 12/13/21
- Wall Street in Fives - Must Read Lists at Midday
- 12/13/21
- Fly Intel: Pre-market Movers
- $136.89 /
-0.225 (-0.16%) - 01/05/22
- Dollar Tree call volume above normal and directionally bullish
- 11/30/21
- Dollar Tree put volume heavy and directionally bearish
- 11/23/21
- Early notable gainers among liquid option names on November 23rd
- 11/15/21
- Early notable gainers among liquid option names on November 15th
|
|
Initiation
|
Truist analyst Scot… Truist analyst Scot Ciccarelli initiated coverage of Dollar Tree with a Buy rating and $162 price target. ShowHide Related Items >><< - $136.94 /
-0.175 (-0.13%) - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- $136.94 /
-0.175 (-0.13%) - 12/14/21 Piper Sandler
- Dollar Tree response to Mantle Ridge 'fell flat,' says Piper Sandler
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- $136.94 /
-0.175 (-0.13%) - 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- $136.94 /
-0.175 (-0.13%) - 11/12/21
- Mantle Ridge builds $1.8B interest in Dollar Tree, WSJ reports
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- $136.94 /
-0.175 (-0.13%) - 01/10/22
- Fly Insider: Orbsat, Airbnb among week's notable insider trades
- 12/13/21
- Wall Street in Fives - Must Read Lists for Monday
- 12/13/21
- Wall Street in Fives - Must Read Lists at Midday
- 12/13/21
- Fly Intel: Pre-market Movers
- $136.94 /
-0.175 (-0.13%) - 01/05/22
- Dollar Tree call volume above normal and directionally bullish
- 11/30/21
- Dollar Tree put volume heavy and directionally bearish
- 11/23/21
- Early notable gainers among liquid option names on November 23rd
- 11/15/21
- Early notable gainers among liquid option names on November 15th
|
|
On The Fly
|
Welcome to "Fly Insider,"… ShowHide Related Items >><< - 01/06/22
- Stitch Fix announces share repurchase authorization of $150M
- 12/07/21
- Stitch Fix CFO says delays in inventory receipts to continue in Q2 and beyond
- 12/07/21
- Stitch Fix CFO expects sequential decline in active users in Q2, growth in Q3
- 12/07/21
- Stitch Fix CFO says FY22 guidance cut due to lower net adds, supply headwinds
- 12/07/21
- EverQuote CEO buys $130.7K in common stock
- 07/20/21
- EverQuote to acquire PolicyFuel for $16M
- 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 01/05/22
- Datadog announces strategic partnership with Amazon Web Services
- 11/24/21
- Datadog director Shah sells $2.4M in company shares
- 11/15/21
- Tiger Global boosts stake in Snowflake, exits TAL Education Group
- 08/04/21
- Datadog launches Datadog Cloud Security Platform
- 09/28/21
- Cardlytics appoints Chris Suh to board of directors
- 11/16/21
- Amkor Technology approves 25% increase in cash dividend to 5c per share
- 11/04/21
- Amkor plans expansion of packaging tech capacity with new factory in Vietnam
- $159.41 /
-6.705 (-4.04%) - 01/07/22
- Zillow Group names Jenny Arden as Chief Design Officer
- 12/15/21
- Block CFO Ahuja to join Airbnb board of directors
- 11/11/21
- AirBNB, DoorDash, Coinbase, Affirm Holdings among names added to U.S. MSCI
- 10/29/21
- Airbnb notes rules against unauthorized parties in place for Halloween 2021
- 12/15/21 JPMorgan
- Cardlytics price target lowered to $73 from $90 at JPMorgan
- 11/03/21 Craig-Hallum
- Cardlytics price target lowered to $100 from $120 at Craig-Hallum
- 08/04/21 Craig-Hallum
- Cardlytics price target lowered to $120 from $160 at Craig-Hallum
- 06/18/21
- Fly Intel: Top five analyst initiations
- 12/15/21 JPMorgan
- EverQuote downgraded to Underweight from Neutral at JPMorgan
- 12/15/21 JPMorgan
- EverQuote downgraded to Underweight from Neutral at JPMorgan
- 11/02/21 Raymond James
- EverQuote price target lowered to $26 from $41 at Raymond James
- 11/02/21 Canaccord
- EverQuote price target lowered to $25 from $30 at Canaccord
- 12/15/21 JPMorgan
- Stitch Fix price target lowered to $20 from $25 at JPMorgan
- 12/08/21
- Fly Intel: Top five analyst downgrades
- 12/08/21 BMO Capital
- Stitch Fix price target lowered to $25 from $40 at BMO Capital
- 12/08/21 Wedbush
- Stitch Fix price target lowered to $21 from $45 at Wedbush
- $159.41 /
-6.705 (-4.04%) - 01/10/22 Piper Sandler
- Airbnb downgraded to Neutral from Overweight at Piper Sandler
- 01/07/22 Jefferies
- Airbnb assumed with a Buy at Jefferies
- 12/16/21 RBC Capital
- Airbnb downgraded to Sector Perform at RBC Capital on 'balanced' risk-reward
- 12/16/21 RBC Capital
- Airbnb downgraded to Sector Perform from Outperform at RBC Capital
- 12/22/21 Sidoti
- Amkor Technology initiated with a Buy at Sidoti
- 10/11/21 Credit Suisse
- Amkor Technology downgraded to Neutral from Outperform at Credit Suisse
- 02/11/21 Citi
- Amkor Technology price target raised to $15 from $13 at Citi
- 01/25/21 Citi
- Citi moves Marvell up to pick in semiconductor equipment
- 01/06/22 Jefferies
- Datadog price target lowered to $200 from $230 at Jefferies
- 12/14/21 JPMorgan
- Datadog downgraded to Underweight from Neutral at JPMorgan
- 12/14/21 JPMorgan
- Datadog downgraded to Neutral from Overweight at JPMorgan
- 11/19/21
- Fly Intel: Top five analyst upgrades
- 12/14/21 Piper Sandler
- Dollar Tree response to Mantle Ridge 'fell flat,' says Piper Sandler
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 12/07/21
- Stitch Fix sees Q2 revenue $505M-$520M, consensus $584.7M
- 12/07/21
- Stitch Fix reports Q1 EPS (2c), consensus (14c)
- 12/07/21
- Notable companies reporting after market close
- 09/21/21
- Stitch Fix sees FY22 revenue up at least 15%, consensus $2.47B
- 08/17/21
- Orbsat reports Q2 net loss ($1.46M) vs. net income $26.6K last year
- 11/01/21
- EverQuote cuts FY21 revenue view to $410M-$415M from $440M-$446M
- 11/01/21
- EverQuote sees Q4 revenue $93.5M-$98.5M, consensus $123.63M
- 11/01/21
- EverQuote reports Q3 EPS (18c), consensus (16c)
- 10/18/21
- EverQuote cuts Q3 revenue view to $106.5M-$107.5M from $109M-$111M
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 11/04/21
- Datadog sees FY21 adjusted EPS 39c-40c, consensus 28c
- 11/04/21
- Datadog sees Q4 adjusted EPS 11c-12c, consensus 6c
- 11/04/21
- Datadog reports Q3 adjusted EPS 13c, consensus 6c
- 11/02/21
- Cardlytics reports Q3 EPS (33c), consensus (54c)
- 08/03/21
- Cardlytics reports Q2 EPS (39c), consensus (39)
- 10/25/21
- Amkor Technology sees Q4 EPS 55c-75c
- 10/25/21
- Amkor Technology reports Q3 EPS 74c vs. 38c last year
- 07/26/21
- Amkor Technology sees Q3 EPS 60c-80c, one estimate 44c
- 07/26/21
- Amkor Technology reports Q2 EPS 51c, one estimate 47c
- $159.41 /
-6.705 (-4.04%) - 11/04/21
- Airbnb sees Q4 revenue $1.39B-$1.48B, consensus $1.44B
- 11/04/21
- Airbnb reports Q3 EPS $1.22, consensus 75c
- 11/04/21
- Notable companies reporting after market close
- 08/12/21
- Airbnb reports Q2 EPS (11c), consensus (48c)
|
|
Conference/Events
|
Loop Capital, along with… Loop Capital, along with Waheed Hassan, former ISS M&A/Proxy Contest Manager, discuss Dollar Tree's potential proxy contest on a conference call to be held on January 14. ShowHide Related Items >><< - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 12/14/21 Piper Sandler
- Dollar Tree response to Mantle Ridge 'fell flat,' says Piper Sandler
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 11/12/21
- Mantle Ridge builds $1.8B interest in Dollar Tree, WSJ reports
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 12/13/21
- Wall Street in Fives - Must Read Lists for Monday
- 12/13/21
- Wall Street in Fives - Must Read Lists at Midday
- 12/13/21
- Fly Intel: Pre-market Movers
- 11/30/21
- Wall Street in Fives - Must Read Lists for Tuesday
- 01/05/22
- Dollar Tree call volume above normal and directionally bullish
- 11/30/21
- Dollar Tree put volume heavy and directionally bearish
- 11/23/21
- Early notable gainers among liquid option names on November 23rd
- 11/15/21
- Early notable gainers among liquid option names on November 15th
|
| Over a month ago |
|
Recommendations
|
Piper Sandler analyst… Piper Sandler analyst Peter Keith raised the firm's price target on Dollar Tree to $147 from $144 and keeps a Neutral rating on the shares. The company's response to activist Mantle Ridge "fell flat and didn't address several key issues," Keith tells investors in a research note. The analyst believes the Dollar Tree board should more seriously consider bringing in Rick Dreiling. He says some of Mantle Ridge's nominations are "quite intriguing." ShowHide Related Items >><< - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 11/29/21 Goldman Sachs
- Dollar Tree downgraded to Neutral from Buy at Goldman Sachs
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 11/12/21
- Mantle Ridge builds $1.8B interest in Dollar Tree, WSJ reports
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 12/13/21
- Wall Street in Fives - Must Read Lists for Monday
- 12/13/21
- Wall Street in Fives - Must Read Lists at Midday
- 12/13/21
- Fly Intel: Pre-market Movers
- 11/30/21
- Wall Street in Fives - Must Read Lists for Tuesday
- 11/30/21
- Dollar Tree put volume heavy and directionally bearish
- 11/23/21
- Early notable gainers among liquid option names on November 23rd
- 11/15/21
- Early notable gainers among liquid option names on November 15th
- 11/02/21
- Unusual call flow in option market yesterday
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 12/07/21
- AT&T CFO says company on track to add at least 1M fiber subscribers in 2021
- 12/07/21
- AT&T selected by DISA for $161M EIS task order
- 12/07/21
- AT&T sees FY22 postpaid phone ARPU remaining stable with 2021 levels
- 12/06/21
- Vera Bradley, Warner Bros debuts new Harry Potter + Vera Bradley collection
- 12/13/21
- Sonoco Products, Asiana Cargo sign global master lease agreement
- 12/10/21
- Sonoco Products provides update on sustainability strategy focus
- 12/10/21
- Sonoco Products targets annual EBITDA growing to $1B by 2026
- 12/02/21
- Sonoco Products to increase tube, core price by 10% in EMEA regions
- $118.90 /
+4.105 (+3.58%) - 12/13/21
- Rivian Automotive's R1T wins MotorTrend truck of the year award
- 11/12/21
- On Rivian, Musk says 'true test' is high production, cash flow breakeven
- 11/08/21
- Rivian Automotive to begin RCV deliveries in early 2023
- 11/07/21
- Fly Intel: Top five weekend stock stories
- 12/07/21
- Peloton announces launch of Peloton Boxing in tweet
- 11/26/21
- Stay-at-home 'pandemic winners' gain in pre-market amid new COVID variant scare
- 11/16/21
- Peloton down 6.8% at $44.25 per share after announcing equity offering
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- 12/12/21
- Pfizer, Sangamo announce updated results from Phase 1/2 Alta study
- 12/08/21
- SOTIO enters clinical collaboration with MSD to evaluate SOT101
- 12/06/21
- Merck announces pause in enrollment for two Phase 3 trials of oral islatravir
- 12/06/21
- Merck Canada announces expansion of manufacturing for molnupiravir
- 12/06/21
- NGM Biopharmaceuticals announces clinical trial collaboration with Merk
- 12/01/21
- Macau reports November casino revenue up 0.01% to 6.75B patacas
- 11/30/21
- Nevada reports October statewide gaming win up 48.54% to $1.22B
- 11/17/21
- New Jersey reports October gaming revenue up 32.7% to $448.7M
- 11/09/21
- MSG Sports, MSG Entertainment enter multi-year marketing partnership with BetMGM
- 12/13/21
- Eli Lilly increases dividend 15% to 98c per share
- 12/12/21
- Loxo Oncology at Lilly announces updated data from Phase 1/2 BRUIN trial
- 11/21/21
- Fly Intel: Top five weekend stock stories
- 11/08/21
- Coca-Cola appoints WPP as global marketing network partner
- 11/01/21
- Coca-Cola acquires remaining stake of Bodyarmor for $5.6B in cash
- 12/10/21
- Janssen EMEA announces conditional marketing authorization for Rybrevant
- 12/10/21
- CDC says in 43 U.S. COVID-19 omicron cases studied, 79% were fully vaccinated
- 12/09/21
- SAGE supports use of JNJ COVID-19 vaccine as booster for persons 18 and older
- 12/09/21
- Johnson & Johnson chief communication officer Michael Sneed to retire
- $29.43 /
-20.57 (-41.14%) - 12/12/21
- IGM presents data from IGM-2323 in patients with Advanced B Cell Malignancies
- 12/08/21
- IGM to collaborate on study of IgM, IgA antibodies to prevent malaria
- 11/04/21
- IGM Biosciences expects to end 2021 with over $200M in cash, investments
- 07/29/21
- IGM Biosciences appoints Chris Takimoto as Chief Medical Officer
- 12/13/21
- Harley-Davidson rises 17.5%
- 12/13/21
- Harley-Davidson rises 12.3%
- 12/13/21
- LiveWire to go public through merger with AEA-Bridges Impact Corp.
- 12/13/21
- LiveWire to go public through merger with AEA-Bridges Impact Corp.
- 11/30/21
- NFL says average viewership of 29.7M for Thanksgiving games 'highest since 1998'
- 10/26/21
- Fox says Fox Nation to launch on YouTube TV as add-on option
- 09/17/21
- Helbiz Media enters deal with Fox Networks to broadcast Serie B championship
- 09/13/21
- Fox Corp. closes deal to acquire TMZ from WarnerMedia
- 08/04/21
- Fox Corp. raises semi-annual dividend to 24c per share
- 12/13/21
- SPX Flow to be acquired by Lone Star Funds for $3.8B
- 11/30/21
- SPX Flow's UHT technology selected by Middle East's dairy producers
- 11/23/21
- SPX Flow up 3% in early trading to $83.96
- 11/16/21
- Henkel installs SPX FLOW mixers for adhesive solutions
FHTX Foghorn Therapeutics - 12/13/21
- Foghorn Therapeutics up 40% in pre-market, discloses 9.7% stake by Eli Lilly
- 12/13/21
- Eli Lilly, Foghorn Therapeutics enter collaboration for novel oncology targets
- 12/02/21
- Foghorn Therapeutics trading resumes
- 12/02/21
- Foghorn Therapeutics trading halted, volatility trading pause
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 12/06/21
- Journey Medical Corp trading resumes
- 12/06/21
- Journey Medical Corp trading halted, volatility trading pause
- 11/29/21
- Journey Medical announces expanded board of directors
- 11/12/21
- Journey Medical prices $35.2M IPO
CCO Clear Channel Outdoor - 12/13/21
- Clear Channel Outdoor rises 11.5%
- 12/13/21
- Clear Channel initiates review of strategic alternatives for European business
- 09/20/21
- Hivestack, Clear Channel Outdoor Americas announce partnership
- 12/13/21
- Bristol-Myers raises dividend 10.2% to 54c per share, adds $15B to buyback plan
- 12/12/21
- Bristol-Myers announces results from interim analysis of TRANSFORM study
- 12/03/21
- Bristol-Myers: FDA accepts for priority review sBLA for Reblozyl
- 11/29/21
- FDA accepts Bristol-Myers' NDA for deucravacitinib in severe plaque psoriasis
- 11/17/21
- Azure Power signs 600 MW PPA with Solar Energy Corporation of India
- 11/11/21
- Azure Power receives LOA for ISTS connected wind-solar hybrid power project
- 09/30/21
- Azure Power names Alan Rosling as new board chairman
- 08/31/21
- Azure Power rises 17.9%
- 12/13/21
- American Express names Wells' Radhakrishnan new CIO with Gordon retiring
- 12/03/21
- Apollo Strategic to take AmEx Global Business Travel public in $5.3B deal
- 12/03/21
- Sabre, American Express Global Business Travel announce partnership
- 11/15/21
- Berkhire Hathaway buys Royalty Pharma, exits Merck in Q3
ARNA Arena Pharmaceuticals - $90.03 /
+40.26 (+80.89%) - 12/13/21
- Pfizer 'confident' regulators will clear deal for Arena Pharmaceuticals
- 12/13/21
- Arena Pharmaceuticals jumps 95% to $97.50 after Pfizer takeover deal
- 12/13/21
- Pfizer to acquire Arena for $100 per share in all-cash transaction
- 11/19/21
- Arena Pharmaceuticals achieves target enrollment in Study A of CULTIVATE trial
- $3,393.04 /
-52.96 (-1.54%) - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/10/21
- Cinedigm renews agreement with Prime Video Channels
- 12/09/21
- Amazon settles false advertising lawsuit with industry organization CCMI
- 12/09/21
- iPower launches first nutrient product line 'Flourish' on Amazon
- 11/18/21
- Archer Daniels makes equity investment in FBN's capital funding raise
- 11/15/21
- Archer Daniels forming Joint Venture in Singapore for alternative protein
- 11/02/21
- Archer Daniels to acquire Deerland Probiotics & Enzymes, terms undisclosed
- 10/29/21
- Flotek enters lawsuit settlement agreement with Archer Daniels
- 12/08/21
- Hyatt introduces room keys in Apple Wallet
- 12/07/21
- Jamf announces its platform has helped deploy one million Macs
- 12/01/21
- Tesla CEO unveils $50 Cyberwhistle inspired by Cybertruck
- $3,393.04 /
-52.96 (-1.54%) - 12/14/21 UBS
- United Natural Foods initiated with a Buy at UBS
- 12/13/21 Cowen
- Amazon price target raised to $4,500, called a Best Idea for 2022 at Cowen
- 12/10/21 JPMorgan
- AWS change could lead to revenue lift at Similarweb, says JPMorgan
- 12/09/21 Baird
- GameStop transformation details 'remain a mystery,' says Baird
ARNA Arena Pharmaceuticals - $90.03 /
+40.26 (+80.89%) - 12/14/21 Jefferies
- Arena Pharmaceuticals downgraded to Hold from Buy at Jefferies
- 12/14/21 Credit Suisse
- Arena Pharmaceuticals downgraded to Neutral from Outperform at Credit Suisse
- 12/14/21 Wells Fargo
- Arena Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
- 12/14/21 Citi
- Arena Pharmaceuticals downgraded to Neutral from Buy at Citi
- 12/14/21 Mizuho
- Pfizer price target raised to $56 from $44 at Mizuho
- $118.90 /
+4.105 (+3.58%) - 12/10/21 Tigress Financial
- Rivian Automotive initiated with a Buy at Tigress Financial
- 12/06/21
- Fly Intel: Top five analyst initiations
- 12/06/21 Wedbush
- Wedbush initiates Rivian Automotive with an Outperform, $130 price target
- 12/06/21 Wolfe Research
- Rivian Automotive initiated with an Outperform at Wolfe Research
- 12/13/21 Stifel
- SPX Flow downgraded to Hold from Buy at Stifel
- 12/13/21 Baird
- SPX Flow downgraded to Neutral from Outperform at Baird
- 09/27/21 BofA
- SPX Flow reinstated with Underperform at BofA after board rejects offer
- 09/27/21 BofA
- SPX Flow reinitiated with an Underperform at BofA
- 10/29/21 Citi
- Citi upgrades Synchrony to Buy on higher loan growth estiamtes
- 10/25/21 BMO Capital
- American Express price target raised to $151 from $147 at BMO Capital
- 10/25/21 Deutsche Bank
- American Express price target raised to $200 from $190 at Deutsche Bank
- 10/25/21 Stephens
- American Express price target raised to $190 from $180 at Stephens
- 12/13/21
- Fly Intel: Top five analyst upgrades
- 12/13/21 JPMorgan
- JPMorgan upgrades Coca-Cola on building sales momentum into 2022
- 12/13/21 JPMorgan
- Coca-Cola upgraded to Overweight from Neutral at JPMorgan
- 11/23/21 Citi
- Citi 'highly skeptical' Coke would abandon relationship with Monster
- 12/13/21
- Fly Intel: Top five analyst downgrades
- 12/13/21 UBS
- Merck downgraded to Neutral from Buy at UBS
- 12/08/21 Wells Fargo
- Merck initiated with an Overweight at Wells Fargo
- 12/07/21
- Fly Intel: Top five analyst downgrades
- 12/14/21 Evercore ISI
- Apple price target raised to $200 at Evercore ISI, named a top pick for 2022
- 12/14/21 BofA
- BofA upgrades Apple to Buy into 'game-changer' headset launch
- 12/14/21 BofA
- Apple upgraded to Buy from Neutral at BofA
- 12/13/21 Wedbush
- Apple 'on the doorstep' of $3 trillion market cap, says Wedbush
- 12/14/21 Barclays
- Braze initiated with an Overweight at Barclays
- 12/13/21
- Fly Intel: Top five analyst initiations
- 12/13/21 Loop Capital
- Braze initiated with a Buy at Loop Capital
- 12/13/21 Loop Capital
- Braze initiated with a Buy at Loop Capital
- 11/29/21 Credit Suisse
- Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
- 11/09/21 Mizuho
- Alkermes price target lowered to $33 from $36 at Mizuho
- 11/08/21 Morgan Stanley
- Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
- 10/20/21 Raymond James
- Johnson & Johnson price target lowered to $178 from $183 at Raymond James
- 12/14/21 Macquarie
- Fox Corp. price target lowered to $37 from $40 at Macquarie
- 08/05/21 Guggenheim
- Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
- 05/06/21 RBC Capital
- Fox Corp. price target raised to $42 from $36 at RBC Capital
- 05/06/21 UBS
- Fox Corp price target raised to $39 from $30 at UBS
- 11/04/21 Deutsche Bank
- Fox Corp. price target raised to $47 from $43 at Deutsche Bank
- 09/30/21
- Fly Intel: Top five analyst upgrades
- 09/30/21 Rosenblatt
- Rosenblatt upgrades Fox on expected favorable FanDuel outcome
- 12/07/21 Citi
- AT&T price target lowered to $29 from $31 at Citi
- 11/11/21 Lake Street
- Smith Micro target raised to $9 at Lake Street after 'major' T-Mobile milestone
- 10/19/21 Citi
- AT&T price target lowered to $30 from $32 at Citi
- 10/14/21
- Fly Intel: Top five analyst upgrades
- 12/14/21 CBRE
- MGM's 'record multiple' for Mirage positive for Wynn and Caesars, says CBRE
- 12/07/21 CBRE
- MGM Resorts resumed with a Buy at CBRE
- 11/23/21 Morgan Stanley
- MGM Resorts resumed with an Equal Weight at Morgan Stanley
- 11/04/21 Stifel
- MGM Resorts price target raised to $54 from $45 at Stifel
- 12/10/21 Baird
- Peloton downgrade today provided no new concerns, says Baird
- 12/10/21 BMO Capital
- BMO wonders if Peloton is losing control of image after character's death
- 12/10/21
- Fly Intel: Top five analyst downgrades
- 12/10/21 Credit Suisse
- Peloton downgraded to Neutral from Outperform at Credit Suisse
GNAC Group Nine Acquisition - 12/08/21 Wells Fargo
- Bristol-Myers initiated with an Equal Weight at Wells Fargo
- 11/23/21 Societe Generale
- Societe Generale upgrades AbbVie to Buy on better than anticipated execution
- 11/18/21 BMO Capital
- Bristol-Myers initiated with an Outperform at BMO Capital
- 11/15/21 Evercore ISI
- Ventyx Biosciences initiated with an Outperform at Evercore ISI
FHTX Foghorn Therapeutics - 11/22/21 H.C. Wainwright
- Foghorn Therapeutics initiated with a Buy at H.C. Wainwright
- 10/28/21 BMO Capital
- Harley-Davidson price target raised to $62 from $54 at BMO Capital
- 09/10/21 Tigress Financial
- Harley-Davidson shares have 47% upside potential, says Tigress Financial
- 09/09/21 Wedbush
- Harley-Davidson price target lowered to $54 from $60 at Wedbush
- 07/27/21 Edward Jones
- Harley-Davidson downgraded to Sell from Hold at Edward Jones
- 12/08/21 Wells Fargo
- Eli Lilly initiated with an Equal Weight at Wells Fargo
- 11/30/21 Canaccord
- Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
- 11/29/21 Morgan Stanley
- Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
- 11/24/21 Truist
- Eli Lilly price target raised to $301 from $262 at Truist
IMPX AEA-Bridges Impact Corp. - $29.43 /
-20.57 (-41.14%) - 12/14/21 Baird
- IGM Biosciences price target lowered to $65 from $90 at Baird
- 12/13/21 Morgan Stanley
- Morgan Stanley cuts IGM Biosciences as lack of dose response raises concerns
- 12/13/21 Morgan Stanley
- IGM Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/14/21 Piper Sandler
- Dollar Tree response to Mantle Ridge 'fell flat,' says Piper Sandler
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 09/01/21 Roth Capital
- Azure Power price target lowered to $40 from $53 at Roth Capital
- 09/01/21 Barclays
- Azure Power price target lowered to $30 from $37 at Barclays
- 06/17/21 Barclays
- Azure Power price target lowered to $37 from $45 at Barclays
- 04/06/21 RBC Capital
- RBC starts India solar power play Azure Power at Outperform
CCO Clear Channel Outdoor - 11/11/21
- Fly Intel: Top five analyst upgrades
- 11/11/21 Barrington
- Clear Channel Outdoor upgraded to Outperform with $5 target at Barrington
- 11/11/21 Barrington
- Clear Channel Outdoor upgraded to Outperform from Market Perform at Barrington
- 11/10/21 Citi
- Clear Channel Outdoor price target raised to $3.50 from $2.75 at Citi
- 12/13/21 Barclays
- Archer Daniels price target raised to $80 from $75 at Barclays
- 10/27/21 Monness Crespi
- Archer Daniels price target raised to $74 from $70 at Monness Crespi
- 10/12/21
- Fly Intel: Top five analyst downgrades
- 10/12/21 Stephens
- Archer Daniels downgraded to Equal Weight from Overweight at Stephens
- 10/14/21 BofA
- Sonoco Products downgraded to Underperform from Neutral at BofA
- 10/14/21 BofA
- Sonoco Products downgraded to Underperform from Neutral at BofA
- 04/19/21 Deutsche Bank
- Sonoco Products price target raised to $63 from $61 at Deutsche Bank
- 04/16/21 Seaport Global
- Sonoco Products downgraded to Neutral from Buy at Seaport Global
- 12/07/21 B. Riley
- Journey Medical initiated with Buy, $14 target at B. Riley
- 12/07/21 B. Riley
- Journey Medical initiated with a Buy at B. Riley
- 11/03/21
- Discovery reports Q3 EPS 24c, consensus 41c
- 10/21/21
- AT&T sees FY21 adjusted EPS at high end of low- to mid-single digit growth
- 10/21/21
- AT&T reports Q3 adjusted EPS 87c, consensus 78c
- 10/20/21
- Notable companies reporting before tomorrow's open
- 12/10/21
- Sonoco Products sees 2022 base EPS $3.85-$3.95, consensus $3.84
- 12/10/21
- Sonoco Products sees 2021 base EPS at top end of $3.49-$3.55
- 12/10/21
- Sonoco Products sees Q4 base EPS at top end of 84c-90c
- 10/21/21
- Sonoco Products sees FY21 base EPS $3.49-$3.55, consensus $3.55
- 11/04/21
- Peloton sees Q2 revenue $1.1B-$1.2B, consensus $1.51B
- 11/04/21
- Peloton sees FY22 revenue $4.4B-$4.8B, consensus $5.4B
- 11/04/21
- Peloton reports Q1 EPS ($1.25), consensus ($1.07)
- 11/04/21
- Notable companies reporting after market close
- 11/02/21
- Pfizer raises FY21 adjusted EPS view to $4.13-$4.18 from $3.95-$4.05
- 11/02/21
- Pfizer reports Q3 adjusted EPS $1.34 vs. 59c a year ago
- 11/01/21
- Notable companies reporting before tomorrow's open
- 10/28/21
- Merck raises FY21 adjusted EPS view to $5.65-$5.70, consensus $5.77
- 10/28/21
- Merck reports Q3 adjusted EPS $1.75, consensus $1.55
- 10/27/21
- Notable companies reporting before tomorrow's open
- 11/03/21
- MGM Resorts reports Q3 adjusted EPS 3c, consensus (1c)
- 08/04/21
- MGM Resorts reports Q2 adjusted EPS (13c), consensus (44c)
- 08/04/21
- IAC reports Q2 EPS $2.02 vs. ($1.13) last year
- 08/04/21
- Notable companies reporting after market close
- 11/09/21
- Eli Lilly and Incyte presents results from Olumiant study
- 10/26/21
- Eli Lilly raises FY21 adjusted EPS view to $7.95-$8.05 from $7.80-$8.00
- 10/26/21
- Eli Lilly reports Q3 EPS $1.94, consensus $1.68
- 10/25/21
- Notable companies reporting before tomorrow's open
- 10/27/21
- Coca-Cola provides FY22 guidance
- 10/27/21
- Coca-Cola sees FY21 organic revenue growth 13%-14%, consensus $37.92B
- 10/27/21
- Coca-Cola reports Q3 adjusted EPS 65c, consensus 58c
- 10/26/21
- Notable companies reporting before tomorrow's open
- 10/19/21
- Johnson & Johnson raises FY21 adjusted EPS view to $9.65-$9.70 from $9.50-$9.60
- 10/19/21
- Johnson & Johnson reports Q3 adjusted EPS $2.60, consensus $2.35
- 10/18/21
- Notable companies reporting before tomorrow's open
- $29.43 /
-20.57 (-41.14%) - 11/04/21
- IGM Biosciences reports Q3 EPS ($1.32), consensus ($1.37)
- 08/09/21
- IGM Biosciences reports Q2 EPS ($1.16), consensus ($1.17)
- 10/27/21
- Harley-Davidson reports Q3 adjusted EPS $1.18, consensus 70c
- 07/21/21
- Harley-Davidson reports Q2 adjusted EPS $1.41, consensus $1.17
- 08/06/21
- Comscore expands relationship with Fox
- 11/03/21
- Fox Corp. reports Q1 adjusted EPS $1.11, consensus $1.03
- 11/03/21
- Notable companies reporting after market close
- 08/04/21
- Fox Corp. reports Q4 adjusted EPS 65c, consensus 57c
- 11/10/21
- SPX Flow reports Q3 adjusted EPS 79c, consensus 70c
- 08/04/21
- SPX Flow reports Q2 adjusted EPS 63c, consensus 59c
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 12/10/21
- Journey Medical reports Q3 adjusted EPS 32c vs. 6c last year
CCO Clear Channel Outdoor - 12/13/21
- Clear Channel Outdoor raises Q4 revenue view to $730M-$750M from $715M-$740M
- 11/09/21
- Clear Channel Outdoor sees Q4 revenue $715M-$740M, consensus $676.8M
- 11/09/21
- Clear Channel Outdoor reports Q3 revenue $596.42M, consensus $589.02M
- 07/29/21
- Clear Channel Outdoor reports Q2 revenue $531.08M, consensus $496.42M
- 10/27/21
- Acceleron expects Q3 royalty revenue of approximately $32M from Reblozy
- 10/27/21
- Bristol-Myers narrows FY21 non-GAAP EPS view to $7.40-$7.55 from $7.35-$7.55
- 10/27/21
- Bristol-Myers reports Q3 EPS $2.00, consensus $1.92
- 12/10/21
- Azure Power backs FY22 revenue view $241M-$255M
- 12/10/21
- Azure Power sees Q3 revenue $55.3M-$58M, consensus $58.3M
- 12/10/21
- Azure Power reports Q2 EPS (INR6.49) vs (INR7.73)
- 08/30/21
- Azure Power sees FY22 revenue $241M-$254M from $244.09M
- 10/22/21
- American Express reports Q3 EPS $2.27, consensus $1.80
- 10/21/21
- Notable companies reporting before tomorrow's open
- 07/23/21
- American Express reports Q2 EPS $2.80, consensus $1.58
ARNA Arena Pharmaceuticals - $90.03 /
+40.26 (+80.89%) - 11/04/21
- Arena Pharmaceuticals reports Q3 adjusted EPS ($3.21), consensus ($2.53)
- 08/05/21
- Arena Pharmaceuticals reports Q2 EPS ($2.40), consensus ($2.19)
- $3,393.04 /
-52.96 (-1.54%) - 11/10/21
- Affirm sees fiscal 2022 revenue $1.225B-$1.25B, consensus $1.20B
- 10/28/21
- Amazon sees Q4 revenue $130B-$140B, consensus $142.05B
- 10/28/21
- Amazon reports Q3 EPS $6.12, consensus $8.92
- 10/28/21
- Notable companies reporting after market close
- 12/13/21
- Archer Daniels targets EPS $6.00-$7.00 by 2025
- 12/10/21
- Archer Daniels sees FY25 EPS $6.00-$7.00
- 10/26/21
- Archer Daniels reports Q3 EPS 97c, consensus 89c
- 10/28/21
- Apple reports Q4 EPS $1.24, consensus $1.24
- 07/30/21
- Musk sides with Epic, says Apple fees 'de facto global tax' on internet
- 07/27/21
- Apple reports Q3 EPS $1.30, consensus $1.00
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 12/13/21
- Exxon Mobil, Scepter to detect methane emissions at global scale
- 12/10/21
- Exxon Mobil VP Wojnar sells 12,512 common shares
- 12/07/21
- Exxon Mobil acquires Materia, terms not disclosed
- 12/07/21
- AT&T CFO says company on track to add at least 1M fiber subscribers in 2021
- 12/07/21
- AT&T selected by DISA for $161M EIS task order
- 12/07/21
- AT&T sees FY22 postpaid phone ARPU remaining stable with 2021 levels
- 12/06/21
- Vera Bradley, Warner Bros debuts new Harry Potter + Vera Bradley collection
- 12/13/21
- Sonoco Products, Asiana Cargo sign global master lease agreement
- 12/10/21
- Sonoco Products provides update on sustainability strategy focus
- 12/10/21
- Sonoco Products targets annual EBITDA growing to $1B by 2026
- 12/02/21
- Sonoco Products to increase tube, core price by 10% in EMEA regions
- 12/13/21
- Starbucks China says 'deeply shocked' by food safety issues reported at 2 stores
- 12/09/21
- Union declares 'Victory at Elmwood' in Starbucks unionization vote
- 12/07/21
- Starbucks CEO: We respect the process we're going through with the NLRB
- 11/19/21
- Electronic Arts names Starbucks exec Rachel Gonzalez to board of directors
- 10/21/21
- SAP sees FY21 cloud revenue up 16%-19%
- 10/18/21
- Electric Last Mile Solutions, SAP partnering for ERP solution
- 09/15/21
- Infosys, SAP collaborate to provide business process transformation-as-a-service
- 09/14/21
- SAP, Amazon.com partner to expand buyer choice
- 12/10/21
- R.R. Donnelley board determines Chatham's acquisition proposal 'superior'
- 12/09/21
- Chatham Asset raises offer to acquire R.R. Donnelley to $10.85 per share in cash
- 12/09/21
- RR Donnelley and Sons trading resumes
- 12/09/21
- R.R. Donnelley board accepts revised proposal from Atlas for $10.35 per share
- $117.63 /
+2.835 (+2.47%) - 12/13/21
- Rivian Automotive's R1T wins MotorTrend truck of the year award
- 11/12/21
- On Rivian, Musk says 'true test' is high production, cash flow breakeven
- 11/08/21
- Rivian Automotive to begin RCV deliveries in early 2023
- 11/07/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Pfizer, Sangamo announce updated results from Phase 1/2 Alta study
- 12/08/21
- SOTIO enters clinical collaboration with MSD to evaluate SOT101
- 12/06/21
- Merck announces pause in enrollment for two Phase 3 trials of oral islatravir
- 12/06/21
- Merck Canada announces expansion of manufacturing for molnupiravir
- 12/06/21
- NGM Biopharmaceuticals announces clinical trial collaboration with Merk
- 12/01/21
- Macau reports November casino revenue up 0.01% to 6.75B patacas
- 11/30/21
- Nevada reports October statewide gaming win up 48.54% to $1.22B
- 11/17/21
- New Jersey reports October gaming revenue up 32.7% to $448.7M
- 11/09/21
- MSG Sports, MSG Entertainment enter multi-year marketing partnership with BetMGM
- 12/12/21
- Loxo Oncology at Lilly announces updated data from Phase 1/2 BRUIN trial
- 12/10/21
- Eli Lilly, Regor enter deal to discover therapies for metabolic disorders
- 11/21/21
- Fly Intel: Top five weekend stock stories
- 11/15/21
- Berkhire Hathaway buys Royalty Pharma, exits Merck in Q3
- 11/08/21
- Coca-Cola appoints WPP as global marketing network partner
- 11/01/21
- Coca-Cola acquires remaining stake of Bodyarmor for $5.6B in cash
- 12/10/21
- Janssen EMEA announces conditional marketing authorization for Rybrevant
- 12/10/21
- CDC says in 43 U.S. COVID-19 omicron cases studied, 79% were fully vaccinated
- 12/09/21
- SAGE supports use of JNJ COVID-19 vaccine as booster for persons 18 and older
- 12/09/21
- Johnson & Johnson chief communication officer Michael Sneed to retire
- $26.19 /
-23.81 (-47.62%) - 12/12/21
- IGM presents data from IGM-2323 in patients with Advanced B Cell Malignancies
- 12/08/21
- IGM to collaborate on study of IgM, IgA antibodies to prevent malaria
- 11/04/21
- IGM Biosciences expects to end 2021 with over $200M in cash, investments
- 07/29/21
- IGM Biosciences appoints Chris Takimoto as Chief Medical Officer
- 12/13/21
- Harley-Davidson rises 17.5%
- 12/13/21
- Harley-Davidson rises 12.3%
- 12/13/21
- LiveWire to go public through merger with AEA-Bridges Impact Corp.
- 12/13/21
- LiveWire to go public through merger with AEA-Bridges Impact Corp.
- 11/30/21
- NFL says average viewership of 29.7M for Thanksgiving games 'highest since 1998'
- 10/26/21
- Fox says Fox Nation to launch on YouTube TV as add-on option
- 09/17/21
- Helbiz Media enters deal with Fox Networks to broadcast Serie B championship
- 09/13/21
- Fox Corp. closes deal to acquire TMZ from WarnerMedia
- 08/04/21
- Fox Corp. raises semi-annual dividend to 24c per share
- 12/13/21
- SPX Flow to be acquired by Lone Star Funds for $3.8B
- 11/30/21
- SPX Flow's UHT technology selected by Middle East's dairy producers
- 11/23/21
- SPX Flow up 3% in early trading to $83.96
- 11/16/21
- Henkel installs SPX FLOW mixers for adhesive solutions
FHTX Foghorn Therapeutics - 12/13/21
- Foghorn Therapeutics up 40% in pre-market, discloses 9.7% stake by Eli Lilly
- 12/13/21
- Eli Lilly, Foghorn Therapeutics enter collaboration for novel oncology targets
- 12/02/21
- Foghorn Therapeutics trading resumes
- 12/02/21
- Foghorn Therapeutics trading halted, volatility trading pause
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 12/06/21
- Journey Medical Corp trading resumes
- 12/06/21
- Journey Medical Corp trading halted, volatility trading pause
- 11/29/21
- Journey Medical announces expanded board of directors
- 11/12/21
- Journey Medical prices $35.2M IPO
CCO Clear Channel Outdoor - 12/13/21
- Clear Channel Outdoor rises 11.5%
- 12/13/21
- Clear Channel initiates review of strategic alternatives for European business
- 09/20/21
- Hivestack, Clear Channel Outdoor Americas announce partnership
- 12/13/21
- Bristol-Myers raises dividend 10.2% to 54c per share, adds $15B to buyback plan
- 12/12/21
- Bristol-Myers announces results from interim analysis of TRANSFORM study
- 12/03/21
- Bristol-Myers: FDA accepts for priority review sBLA for Reblozyl
- 11/29/21
- FDA accepts Bristol-Myers' NDA for deucravacitinib in severe plaque psoriasis
- 11/17/21
- Azure Power signs 600 MW PPA with Solar Energy Corporation of India
- 11/11/21
- Azure Power receives LOA for ISTS connected wind-solar hybrid power project
- 09/30/21
- Azure Power names Alan Rosling as new board chairman
- 08/31/21
- Azure Power rises 17.9%
ARNA Arena Pharmaceuticals - $90.54 /
+40.77 (+81.92%) - 12/13/21
- Pfizer 'confident' regulators will clear deal for Arena Pharmaceuticals
- 12/13/21
- Arena Pharmaceuticals jumps 95% to $97.50 after Pfizer takeover deal
- 12/13/21
- Pfizer to acquire Arena for $100 per share in all-cash transaction
- 11/19/21
- Arena Pharmaceuticals achieves target enrollment in Study A of CULTIVATE trial
- $3,392.98 /
-53.02 (-1.54%) - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/10/21
- Cinedigm renews agreement with Prime Video Channels
- 12/09/21
- Amazon settles false advertising lawsuit with industry organization CCMI
- 12/09/21
- iPower launches first nutrient product line 'Flourish' on Amazon
- 11/18/21
- Archer Daniels makes equity investment in FBN's capital funding raise
- 11/15/21
- Archer Daniels forming Joint Venture in Singapore for alternative protein
- 11/02/21
- Archer Daniels to acquire Deerland Probiotics & Enzymes, terms undisclosed
- 10/29/21
- Flotek enters lawsuit settlement agreement with Archer Daniels
- 12/08/21
- Hyatt introduces room keys in Apple Wallet
- 12/07/21
- Jamf announces its platform has helped deploy one million Macs
- 12/01/21
- Tesla CEO unveils $50 Cyberwhistle inspired by Cybertruck
- $3,392.98 /
-53.02 (-1.54%) - 12/13/21 Cowen
- Amazon price target raised to $4,500, called a Best Idea for 2022 at Cowen
- 12/10/21 JPMorgan
- AWS change could lead to revenue lift at Similarweb, says JPMorgan
- 12/09/21 Baird
- GameStop transformation details 'remain a mystery,' says Baird
- 12/06/21 Lake Street
- Backblaze initiated with a Buy at Lake Street
ARNA Arena Pharmaceuticals - $90.54 /
+40.77 (+81.92%) - 12/13/21 Needham
- Arena Pharmaceuticals downgraded to Hold from Buy at Needham
- 12/13/21 Citi
- Arena 'highly attractive' for Pfizer, but FTC a concern, says Citi
- 12/13/21 Piper Sandler
- Piper keeps $50 target on Ventyx after Pfizer buys Arena
- 12/08/21 Wells Fargo
- Arena Pharmaceuticals initiated with an Overweight at Wells Fargo
- 12/13/21
- Fly Intel: Top five analyst upgrades
- 12/13/21 UBS
- Pfizer upgraded to Buy from Neutral at UBS
- 12/08/21 Wells Fargo
- Bristol-Myers initiated with an Equal Weight at Wells Fargo
- 11/23/21 Societe Generale
- Societe Generale upgrades AbbVie to Buy on better than anticipated execution
- 11/18/21 BMO Capital
- Bristol-Myers initiated with an Outperform at BMO Capital
- 11/15/21 Evercore ISI
- Ventyx Biosciences initiated with an Outperform at Evercore ISI
- 12/13/21 Stifel
- SPX Flow downgraded to Hold from Buy at Stifel
- 12/13/21 Baird
- SPX Flow downgraded to Neutral from Outperform at Baird
- 09/27/21 BofA
- SPX Flow reinstated with Underperform at BofA after board rejects offer
- 09/27/21 BofA
- SPX Flow reinitiated with an Underperform at BofA
- 11/29/21 Credit Suisse
- Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
- 11/09/21 Mizuho
- Alkermes price target lowered to $33 from $36 at Mizuho
- 11/08/21 Morgan Stanley
- Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
- 10/20/21 Raymond James
- Johnson & Johnson price target lowered to $178 from $183 at Raymond James
- $117.63 /
+2.835 (+2.47%) - 12/10/21 Tigress Financial
- Rivian Automotive initiated with a Buy at Tigress Financial
- 12/06/21
- Fly Intel: Top five analyst initiations
- 12/06/21 Wedbush
- Wedbush initiates Rivian Automotive with an Outperform, $130 price target
- 12/06/21 Wolfe Research
- Rivian Automotive initiated with an Outperform at Wolfe Research
- 12/13/21 Baird
- China state-owned media report could bring Starbucks backlash, says Baird
- 12/07/21
- Fly Intel: Top five analyst upgrades
- 12/07/21 MKM Partners
- Starbucks upgraded to Buy from Neutral at MKM Partners
- 11/04/21
- Fly Intel: Top five analyst downgrades
- 08/05/21 Guggenheim
- Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
- 05/06/21 RBC Capital
- Fox Corp. price target raised to $42 from $36 at RBC Capital
- 05/06/21 UBS
- Fox Corp price target raised to $39 from $30 at UBS
- 04/27/21 Morgan Stanley
- Fox Corp. price target raised to $45 from $36 at Morgan Stanley
- 11/04/21 Deutsche Bank
- Fox Corp. price target raised to $47 from $43 at Deutsche Bank
- 09/30/21
- Fly Intel: Top five analyst upgrades
- 09/30/21 Rosenblatt
- Rosenblatt upgrades Fox on expected favorable FanDuel outcome
- 09/30/21 Rosenblatt
- Fox Corp. upgraded to Buy from Neutral at Rosenblatt
- 12/07/21 Citi
- AT&T price target lowered to $29 from $31 at Citi
- 11/11/21 Lake Street
- Smith Micro target raised to $9 at Lake Street after 'major' T-Mobile milestone
- 10/19/21 Citi
- AT&T price target lowered to $30 from $32 at Citi
- 10/14/21
- Fly Intel: Top five analyst upgrades
- 12/07/21 CBRE
- MGM Resorts resumed with a Buy at CBRE
- 11/23/21 Morgan Stanley
- MGM Resorts resumed with an Equal Weight at Morgan Stanley
- 11/04/21 Stifel
- MGM Resorts price target raised to $54 from $45 at Stifel
- 11/04/21 Wells Fargo
- MGM Resorts price target raised to $62 from $55 at Wells Fargo
- 12/09/21 JPMorgan
- Exxon Mobil price target raised to $83 from $81 at JPMorgan
- 12/08/21 Barclays
- Exxon Mobil price target raised to $73 from $71 at Barclays
- 11/02/21
- Fly Intel: Top five analyst downgrades
- 11/02/21 Truist
- Exxon Mobil downgraded to Sell from Hold at Truist
FHTX Foghorn Therapeutics - 11/22/21 H.C. Wainwright
- Foghorn Therapeutics initiated with a Buy at H.C. Wainwright
- 12/08/21 Wells Fargo
- Eli Lilly initiated with an Equal Weight at Wells Fargo
- 11/30/21 Canaccord
- Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
- 11/29/21 Morgan Stanley
- Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
- 11/24/21 Truist
- Eli Lilly price target raised to $301 from $262 at Truist
- 10/28/21 BMO Capital
- Harley-Davidson price target raised to $62 from $54 at BMO Capital
- 09/10/21 Tigress Financial
- Harley-Davidson shares have 47% upside potential, says Tigress Financial
- 09/09/21 Wedbush
- Harley-Davidson price target lowered to $54 from $60 at Wedbush
- 07/27/21 Edward Jones
- Harley-Davidson downgraded to Sell from Hold at Edward Jones
IMPX AEA-Bridges Impact Corp. - $26.19 /
-23.81 (-47.62%) - 12/13/21
- Fly Intel: Top five analyst downgrades
- 12/13/21 RBC Capital
- IGM Biosciences downgraded to Sector Perform from Outperform at RBC Capital
- 12/13/21 Stifel
- IGM Biosciences price target lowered to $65 from $98 at Stifel
- 12/13/21 Wedbush
- IGM Biosciences price target lowered to $67 from $82 at Wedbush
- 12/13/21 Wells Fargo
- Mantle changes would be 'large wins' for Dollar Tree holders, says Wells Fargo
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 11/29/21 Goldman Sachs
- Dollar Tree downgraded to Neutral from Buy at Goldman Sachs
- 09/01/21 Roth Capital
- Azure Power price target lowered to $40 from $53 at Roth Capital
- 09/01/21 Barclays
- Azure Power price target lowered to $30 from $37 at Barclays
- 06/17/21 Barclays
- Azure Power price target lowered to $37 from $45 at Barclays
- 04/06/21 RBC Capital
- RBC starts India solar power play Azure Power at Outperform
CCO Clear Channel Outdoor - 11/11/21
- Fly Intel: Top five analyst upgrades
- 11/11/21 Barrington
- Clear Channel Outdoor upgraded to Outperform with $5 target at Barrington
- 11/11/21 Barrington
- Clear Channel Outdoor upgraded to Outperform from Market Perform at Barrington
- 11/10/21 Citi
- Clear Channel Outdoor price target raised to $3.50 from $2.75 at Citi
- 12/13/21 Barclays
- Archer Daniels price target raised to $80 from $75 at Barclays
- 10/27/21 Monness Crespi
- Archer Daniels price target raised to $74 from $70 at Monness Crespi
- 10/12/21
- Fly Intel: Top five analyst downgrades
- 10/12/21 Stephens
- Archer Daniels downgraded to Equal Weight from Overweight at Stephens
- 10/14/21 BofA
- Sonoco Products downgraded to Underperform from Neutral at BofA
- 10/14/21 BofA
- Sonoco Products downgraded to Underperform from Neutral at BofA
- 04/19/21 Deutsche Bank
- Sonoco Products price target raised to $63 from $61 at Deutsche Bank
- 04/16/21 Seaport Global
- Sonoco Products downgraded to Neutral from Buy at Seaport Global
- 12/07/21 B. Riley
- Journey Medical initiated with Buy, $14 target at B. Riley
- 12/07/21 B. Riley
- Journey Medical initiated with a Buy at B. Riley
- 12/13/21 JPMorgan
- JPMorgan upgrades Coca-Cola on building sales momentum into 2022
- 12/13/21 JPMorgan
- Coca-Cola upgraded to Overweight from Neutral at JPMorgan
- 11/23/21 Citi
- Citi 'highly skeptical' Coke would abandon relationship with Monster
- 12/13/21 UBS
- Merck downgraded to Neutral from Buy at UBS
- 12/08/21 Wells Fargo
- Merck initiated with an Overweight at Wells Fargo
- 12/07/21
- Fly Intel: Top five analyst downgrades
- 12/13/21 Wedbush
- Apple 'on the doorstep' of $3 trillion market cap, says Wedbush
- 12/13/21 JPMorgan
- JPMorgan ups Apple price target, reiterates as top pick into 2022
- 12/09/21 Barclays
- Barclays says new Google Search app pop-up could signal risk to Apple
- 12/09/21 B. Riley
- B. Riley says 'excellent time' to buy Globalstar on iPhone inclusion evidence
- 12/13/21
- Fly Intel: Top five analyst initiations
- 12/13/21 Loop Capital
- Braze initiated with a Buy at Loop Capital
- 12/13/21 Loop Capital
- Braze initiated with a Buy at Loop Capital
- 12/13/21 Needham
- Needham starts Braze at Buy on early-mover advantage in omni-channel engagement
- 12/13/21 UBS
- SAP upgraded to Buy from Neutral at UBS
- 12/08/21 Morgan Stanley
- SAP price target raised to EUR 142 from EUR 138 at Morgan Stanley
- 10/22/21 Morgan Stanley
- SAP price target raised to EUR 138 from EUR 136 at Morgan Stanley
- 10/29/21
- Exxon Mobil reports Q3 ex-items EPS $1.58, consensus $1.56
- 10/28/21
- Notable companies reporting before tomorrow's open
- 07/30/21
- Exxon Mobil reports Q2 ex-items EPS $1.10, consensus 97c
- 11/03/21
- Discovery reports Q3 EPS 24c, consensus 41c
- 10/21/21
- AT&T sees FY21 adjusted EPS at high end of low- to mid-single digit growth
- 10/21/21
- AT&T reports Q3 adjusted EPS 87c, consensus 78c
- 10/20/21
- Notable companies reporting before tomorrow's open
- 12/10/21
- Sonoco Products sees 2022 base EPS $3.85-$3.95, consensus $3.84
- 12/10/21
- Sonoco Products sees 2021 base EPS at top end of $3.49-$3.55
- 12/10/21
- Sonoco Products sees Q4 base EPS at top end of 84c-90c
- 10/21/21
- Sonoco Products sees FY21 base EPS $3.49-$3.55, consensus $3.55
- 10/28/21
- Starbucks sees FY22 EPS up 'at least 10%' from $3.10 in FY21
- 10/28/21
- Starbucks sees FY22 revenue $32.5B-$33.0B, consensus $32.06B
- 10/28/21
- Starbucks reports Q4 adjusted EPS $1.00, consenus 99c
- 10/21/21
- SAP reports Q3 non-IFRS EPS EUR 1.74 vs EUR 1.70 last year
- 10/12/21
- SAP raises FY21 cloud revenue view to EUR 9.4B-9.6B from EUR 9.3B-9.5B
- 10/12/21
- SAP sees Q3 above market expectations with EPS up 2%, revenue up 3%
- 07/21/21
- SAP reports Q2 non-IFRS EPS EUR 1.75 vs EUR 1.17 last year
- 11/03/21
- R.R. Donnelley reports Q3 adjusted EPS 57c, consensus 32c
- 11/02/21
- Pfizer raises FY21 adjusted EPS view to $4.13-$4.18 from $3.95-$4.05
- 11/02/21
- Pfizer reports Q3 adjusted EPS $1.34 vs. 59c a year ago
- 11/01/21
- Notable companies reporting before tomorrow's open
- 10/28/21
- Merck raises FY21 adjusted EPS view to $5.65-$5.70, consensus $5.77
- 10/28/21
- Merck reports Q3 adjusted EPS $1.75, consensus $1.55
- 10/27/21
- Notable companies reporting before tomorrow's open
- 11/03/21
- MGM Resorts reports Q3 adjusted EPS 3c, consensus (1c)
- 08/04/21
- MGM Resorts reports Q2 adjusted EPS (13c), consensus (44c)
- 08/04/21
- IAC reports Q2 EPS $2.02 vs. ($1.13) last year
- 08/04/21
- Notable companies reporting after market close
- 11/09/21
- Eli Lilly and Incyte presents results from Olumiant study
- 10/26/21
- Eli Lilly raises FY21 adjusted EPS view to $7.95-$8.05 from $7.80-$8.00
- 10/26/21
- Eli Lilly reports Q3 EPS $1.94, consensus $1.68
- 10/25/21
- Notable companies reporting before tomorrow's open
- 10/27/21
- Coca-Cola provides FY22 guidance
- 10/27/21
- Coca-Cola sees FY21 organic revenue growth 13%-14%, consensus $37.92B
- 10/27/21
- Coca-Cola reports Q3 adjusted EPS 65c, consensus 58c
- 10/19/21
- Johnson & Johnson raises FY21 adjusted EPS view to $9.65-$9.70 from $9.50-$9.60
- 10/19/21
- Johnson & Johnson reports Q3 adjusted EPS $2.60, consensus $2.35
- 10/18/21
- Notable companies reporting before tomorrow's open
- $26.19 /
-23.81 (-47.62%) - 11/04/21
- IGM Biosciences reports Q3 EPS ($1.32), consensus ($1.37)
- 08/09/21
- IGM Biosciences reports Q2 EPS ($1.16), consensus ($1.17)
- 10/27/21
- Harley-Davidson reports Q3 adjusted EPS $1.18, consensus 70c
- 07/21/21
- Harley-Davidson reports Q2 adjusted EPS $1.41, consensus $1.17
- 08/06/21
- Comscore expands relationship with Fox
- 11/03/21
- Fox Corp. reports Q1 adjusted EPS $1.11, consensus $1.03
- 11/03/21
- Notable companies reporting after market close
- 08/04/21
- Fox Corp. reports Q4 adjusted EPS 65c, consensus 57c
- 11/10/21
- SPX Flow reports Q3 adjusted EPS 79c, consensus 70c
- 08/04/21
- SPX Flow reports Q2 adjusted EPS 63c, consensus 59c
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 12/10/21
- Journey Medical reports Q3 adjusted EPS 32c vs. 6c last year
CCO Clear Channel Outdoor - 12/13/21
- Clear Channel Outdoor raises Q4 revenue view to $730M-$750M from $715M-$740M
- 11/09/21
- Clear Channel Outdoor sees Q4 revenue $715M-$740M, consensus $676.8M
- 11/09/21
- Clear Channel Outdoor reports Q3 revenue $596.42M, consensus $589.02M
- 07/29/21
- Clear Channel Outdoor reports Q2 revenue $531.08M, consensus $496.42M
- 10/27/21
- Acceleron expects Q3 royalty revenue of approximately $32M from Reblozy
- 10/27/21
- Bristol-Myers narrows FY21 non-GAAP EPS view to $7.40-$7.55 from $7.35-$7.55
- 10/27/21
- Bristol-Myers reports Q3 EPS $2.00, consensus $1.92
- 10/26/21
- Notable companies reporting before tomorrow's open
- 12/10/21
- Azure Power backs FY22 revenue view $241M-$255M
- 12/10/21
- Azure Power sees Q3 revenue $55.3M-$58M, consensus $58.3M
- 12/10/21
- Azure Power reports Q2 EPS (INR6.49) vs (INR7.73)
- 08/30/21
- Azure Power sees FY22 revenue $241M-$254M from $244.09M
ARNA Arena Pharmaceuticals - $90.54 /
+40.77 (+81.92%) - 11/04/21
- Arena Pharmaceuticals reports Q3 adjusted EPS ($3.21), consensus ($2.53)
- 08/05/21
- Arena Pharmaceuticals reports Q2 EPS ($2.40), consensus ($2.19)
- $3,392.98 /
-53.02 (-1.54%) - 11/10/21
- Affirm sees fiscal 2022 revenue $1.225B-$1.25B, consensus $1.20B
- 10/28/21
- Amazon sees Q4 revenue $130B-$140B, consensus $142.05B
- 10/28/21
- Amazon reports Q3 EPS $6.12, consensus $8.92
- 10/28/21
- Notable companies reporting after market close
- 12/13/21
- Archer Daniels targets EPS $6.00-$7.00 by 2025
- 12/10/21
- Archer Daniels sees FY25 EPS $6.00-$7.00
- 10/26/21
- Archer Daniels reports Q3 EPS 97c, consensus 89c
- 10/28/21
- Apple reports Q4 EPS $1.24, consensus $1.24
- 07/30/21
- Musk sides with Epic, says Apple fees 'de facto global tax' on internet
- 07/27/21
- Apple reports Q3 EPS $1.30, consensus $1.00
|
|
Recommendations
|
Activist Mantle Ridge has… Activist Mantle Ridge has accelerated its push for change at Dollar Tree as it is seeking a refresh of the board, a review of the company's strategy, and the hiring of Rick Dreiling to a leadership role, Wells Fargo analyst Edward Kelly tells investors in a research note. The analyst believes these changes "would be large wins for shareholders." Mantle's proposed, mostly independent director slate is "highly impressive," says Kelly. The analyst believes a strategic review seems warranted, especially given the "recent rush to break the $1 price point after an activist came knocking and the historical value destruction at Family Dollar." New that "dollar store icon" Rick Dreiling is interested in day-to-day leadership responsibility "is a huge plus," contends Kelly. The analyst keeps an Overweight rating on Dollar Tree with a $175 price target. ShowHide Related Items >><< - 12/12/21
- Fly Intel: Top five weekend stock stories
- 12/12/21
- Dollar Tree responds to Mantle Ridge's Notice of Nomination of Directors
- 11/23/21
- Dollar Tree expects to complete rollout of $1.25 price point in Q1 of FY22
- 11/12/21
- Mantle Ridge reports 5.7% stake in Dollar Tree, may seek talks
- 11/30/21
- Fly Intel: Top five analyst downgrades
- 11/29/21 Goldman Sachs
- Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
- 11/29/21 Goldman Sachs
- Dollar Tree downgraded to Neutral from Buy at Goldman Sachs
- 11/26/21 Morgan Stanley
- Dollar Tree 'bull case path' to over $200 'getting clearer,' says Morgan Stanley
- 11/23/21
- Dollar Tree narrows FY21 EPS view to $5.48-$5.58 from $5.40-$5.60
- 11/23/21
- Dollar Tree sees Q4 EPS $1.69-$1.79, consensus $1.75
- 11/23/21
- Dollar Tree reports Q3 EPS 96c, consensus 96c
- 11/22/21
- Notable companies reporting before tomorrow's open
- 11/12/21
- Mantle Ridge builds $1.8B interest in Dollar Tree, WSJ reports
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 11/04/21
- Dollar Tree could become target of activist Mantle Ridge, Bloomberg says
- 12/13/21
- Fly Intel: Pre-market Movers
- 11/30/21
- Wall Street in Fives - Must Read Lists for Tuesday
- 11/30/21
- Wall Street in Fives - Must Read Lists at Midday
- 11/30/21
- Square upgrade, Dollar Tree downgrade among today's top calls on Wall Street
- 11/30/21
- Dollar Tree put volume heavy and directionally bearish
- 11/23/21
- Early notable gainers among liquid option names on November 23rd
- 11/15/21
- Early notable gainers among liquid option names on November 15th
- 11/02/21
- Unusual call flow in option market yesterday
|
